The Current Ratio as of November 2024 (TTM) for Wave Life Sciences Ltd. (WVE) is 1.90

According to Wave Life Sciences Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 1.90. This represents a change of 42.29% compared to the average of 1.34 of the last 4 quarters.

Wave Life Sciences Ltd. (WVE) Historical Current Ratio (quarterly & annually)

How has WVE Current Ratio performed in the past?

The mean historical Current Ratio of Wave Life Sciences Ltd. over the last ten years is 7.43. The current 1.90 Current Ratio has changed 2.46% with respect to the historical average. Over the past ten years (40 quarters), WVE's Current Ratio was at its highest in in the December 2015 quarter at 42.27. The Current Ratio was at its lowest in in the March 2015 quarter at 0.

Wave Life Sciences Ltd. (WVE) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Wave Life Sciences Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Wave Life Sciences Ltd. (WVE) Average Current Ratio

How has WVE Current Ratio performed in the past?

The current Current Ratio of Wave Life Sciences Ltd. (WVE) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Wave Life Sciences Ltd. (WVE) Current Ratio vs. Peers

How is WVE’s Current Ratio compared to its peers?

Wave Life Sciences Ltd.’s Current Ratio is less than Arrowhead Pharmaceuticals, Inc. (4.65), greater than CytomX Therapeutics, Inc. (1.04), less than Assembly Biosciences, Inc. (2.36), less than Neoleukin Therapeutics, Inc. (15.33), less than VectivBio Holding AG (9.14), less than Icosavax, Inc. (18.06), less than Apellis Pharmaceuticals, Inc. (4.36), less than iTeos Therapeutics, Inc. (14.80), less than TScan Therapeutics, Inc. (9.56), less than ProQR Therapeutics N.V. (2.33), less than Alnylam Pharmaceuticals, Inc. (2.75), less than Blueprint Medicines Corporation (3.32), less than Terns Pharmaceuticals, Inc. (32.99), less than Amylyx Pharmaceuticals, Inc. (4.55), less than Acumen Pharmaceuticals, Inc. (10.43), less than Inozyme Pharma, Inc. (7.68), less than X4 Pharmaceuticals, Inc. (4.89), less than Day One Biopharmaceuticals, Inc. (14.62), less than Mereo BioPharma Group plc (6.10),

Build a custom stock screener for Wave Life Sciences Ltd. (WVE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Wave Life Sciences Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Wave Life Sciences Ltd. (WVE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Wave Life Sciences Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.